Search Results - "Bray, Susan E."

Refine Results
  1. 1

    ABCB1 (MDR1) induction defines a common resistance mechanism in paclitaxel- and olaparib-resistant ovarian cancer cells by Vaidyanathan, Aparajitha, Sawers, Lynne, Gannon, Anne-Louise, Chakravarty, Probir, Scott, Alison L, Bray, Susan E, Ferguson, Michelle J, Smith, Gillian

    Published in British journal of cancer (09-08-2016)
    “…Background: Clinical response to chemotherapy for ovarian cancer is frequently compromised by the development of drug-resistant disease. The underlying…”
    Get full text
    Journal Article
  2. 2

    IL-15 and PIM kinases direct the metabolic programming of intestinal intraepithelial lymphocytes by James, Olivia J., Vandereyken, Maud, Marchingo, Julia M., Singh, Francois, Bray, Susan E., Wilson, Jamie, Love, Andrew G., Swamy, Mahima

    Published in Nature communications (13-07-2021)
    “…Intestinal intraepithelial lymphocytes (IEL) are an abundant population of tissue-resident T cells that protect and maintain the intestinal barrier. IEL…”
    Get full text
    Journal Article
  3. 3

    MAGE-A Cancer/Testis Antigens Inhibit MDM2 Ubiquitylation Function and Promote Increased Levels of MDM4 by Marcar, Lynnette, Ihrig, Bianca, Hourihan, John, Bray, Susan E, Quinlan, Philip R, Jordan, Lee B, Thompson, Alastair M, Hupp, Ted R, Meek, David W

    Published in PloS one (22-05-2015)
    “…Melanoma antigen A (MAGE-A) proteins comprise a structurally and biochemically similar sub-family of Cancer/Testis antigens that are expressed in many cancer…”
    Get full text
    Journal Article
  4. 4

    The genetic association of the transcription factor NPAT with glycemic response to metformin involves regulation of fuel selection by Chen, Changwei, Gallagher, Jennifer R, Tarlton, Jamie, van Aalten, Lidy, Bray, Susan E, Ashford, Michael L J, McCrimmon, Rory J, Pearson, Ewan R, McNeilly, Alison D, Sutherland, Calum

    Published in PloS one (01-07-2021)
    “…The biguanide, metformin, is the first-choice therapeutic agent for type-2 diabetes, although the mechanisms that underpin metformin clinical efficacy remain…”
    Get full text
    Journal Article
  5. 5

    Multimodality Characterization of Cancer-Associated Fibroblasts in Tumor Microenvironment and Its Correlation With Ultrasound Shear Wave-Measured Tissue Stiffness in Localized Prostate Cancer by Ageeli, Wael, Zhang, Xinyu, Ogbonnaya, Chidozie N, Bray, Susan E, Kernohan, Neil M, Wilson, Jennifer, Li, Chunhui, Nabi, Ghulam

    Published in Frontiers in oncology (21-04-2022)
    “…Growing evidence suggests that the tumor microenvironment (TME) represented by cellular and acellular components plays a key role in the multistep process of…”
    Get full text
    Journal Article
  6. 6

    Histological evaluation of AMPK signalling in primary breast cancer by Hadad, Sirwan M, Baker, Lee, Quinlan, Philip R, Robertson, Katherine E, Bray, Susan E, Thomson, George, Kellock, David, Jordan, Lee B, Purdie, Colin A, Hardie, David G, Fleming, Stewart, Thompson, Alastair M

    Published in BMC cancer (01-09-2009)
    “…AMP-activated protein kinase (AMPK) acts as a cellular fuel gauge that responds to energy stress by suppressing cell growth and biosynthetic processes, thus…”
    Get full text
    Journal Article
  7. 7

    Wnt5a exhibits layer-specific expression in adult skin, is upregulated in psoriasis, and synergizes with type 1 interferon by Romanowska, Malgorzata, Evans, Alan, Kellock, David, Bray, Susan E, McLean, Kathleen, Donandt, Susanne, Foerster, John

    Published in PloS one (28-04-2009)
    “…Wnt5a is a member of the wingless-type patterning regulators important in pre-natal development. The expression and distribution of Wnt5a and its receptors…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Immunohistochemical detection of Polo-like kinase-1 (PLK1) in primary breast cancer is associated with TP53 mutation and poor clinical outcom by King, Sharon I, Purdie, Colin A, Bray, Susan E, Quinlan, Philip R, Jordan, Lee B, Thompson, Alastair M, Meek, David W

    Published in Breast cancer research : BCR (08-03-2012)
    “…Polo-like kinase-1 (PLK1) is a crucial driver of cell cycle progression and its down-regulation plays an important checkpoint role in response to DNA damage…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Immunohistochemical detection of Polo-like kinase-1 (PLK1) in primary breast cancer is associated with TP53 mutation and poor clinical outcome by King, Sharon I, Purdie, Colin A, Bray, Susan E, Quinlan, Philip R, Jordan, Lee B, Thompson, Alastair M, Meek, David W

    Published in Breast cancer research : BCR (01-01-2012)
    “…Polo-like kinase-1 (PLK1) is a crucial driver of cell cycle progression and its down-regulation plays an important checkpoint role in response to DNA damage…”
    Get full text
    Journal Article
  12. 12
  13. 13

    The amino-acid stress sensing eIF2α kinase GCN2 is a survival biomarker for malignant mesothelioma by Gold, Lyssa T, Bray, Susan E, Kernohan, Neil M, Henderson, Nina, Nowicki, Maisie, Masson, Glenn R

    Published in BJC reports (22-06-2023)
    “…Malignant mesothelioma is a tumour that is strongly associated with a history of asbestos exposure, and which derives from mesothelial cells that line the…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Phosphorylation of a splice variant of collapsin response mediator protein 2 in the nucleus of tumour cells links cyclin dependent kinase-5 to oncogenesis by Grant, Nicola J, Coates, Philip J, Woods, Yvonne L, Bray, Susan E, Morrice, Nicholas A, Hastie, C James, Lamont, Douglas J, Carey, Francis A, Sutherland, Calum

    Published in BMC cancer (10-11-2015)
    “…Cyclin-dependent protein kinase-5 (CDK5) is an unusual member of the CDK family as it is not cell cycle regulated. However many of its substrates have roles in…”
    Get full text
    Journal Article
  17. 17

    Differences in the frequency of macrophage and T cell markers between focal and crescentic classes of anti-neutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis by Kidder, Dana, Bray, Susan E, Fleming, Stewart

    Published in Journal of nephropathology (01-03-2017)
    “…Background: Anti-neutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis (AAGN) can be classified into; focal, crescentic, mixed and sclerotic…”
    Get full text
    Journal Article
  18. 18

    Gene expression in colorectal neoplasia: modifications induced by tissue ischaemic time and tissue handling protocol by Bray, Susan E, Paulin, Fiona E M, Fong, Siew Chinn, Baker, Lee, Carey, Frank A, Levison, David A, Steele, Robert J C, Kernohan, Neil M

    Published in Histopathology (01-01-2010)
    “…Bray S E, Paulin F E M, Fong S C, Baker L, Carey F A, Levison D A, Steele R J C & Kernohan N M
(2010) Histopathology56, 240–250 Gene expression in colorectal…”
    Get full text
    Journal Article
  19. 19

    Seliciclib (CYC202, R‐roscovitine) enhances the antitumor effect of doxorubicin in vivo in a breast cancer xenograft model by Appleyard, Maria Virginia C.L., O'Neill, Mary A., Murray, Karen E., Paulin, Fiona E.M., Bray, Susan E., Kernohan, Neil M., Levison, David A., Lane, David P., Thompson, Alastair M.

    Published in International journal of cancer (15-01-2009)
    “…We sought to determine whether seliciclib (CYC202, R‐roscovitine) could increase the antitumor effects of doxorubicin, with no increase in toxicity, in an MCF7…”
    Get full text
    Journal Article
  20. 20